← Open Payments lookup

IFEOMA ARENE: Open Payments

NPI 1780642488 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,115 in 123 payments from 19 companies in 2025. Trend: 2023 $2,016 · 2024 $2,137 · 2025 $2,115

Food & beverage: $2,115
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.22$412
Neurocrine BioSciences, Inc.12$234
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$203
ABBVIE INC.13$198
Alkermes, Inc.18$188
Indivior Inc.7$171
Lundbeck LLC9$145
Tris Pharma Inc9$135
Axsome Therapeutics, Inc.4$117
Corium, LLC5$74

Products named: REXULTI, INGREZZA, CAPLYTA, VRAYLAR, SUBLOCADE, ARISTADA, Auvelity, Dyanavel XR.

Industry payments across TX — which companies pay providers there.